Vesicle interactions with polyamino acids and antibody: in vitro and in vivo studies.
Artificial spherules or vesicles of 900 A in diameter formed from phosphatidylcholine and gangliosides and enclosing 99mTcO4 - (standard preparation) survive intact in the circulation of the mouse. Polyamino acids and protein have been incorporated into and onto the vesicles; such vesicles remain intact as determined by diffusion dialysis studies and by electron paramagnetic resonance studies of vesicles enclosing spin label. In studying the distribution of polyamino acid-vesicles and protein vesicles in vivo, it was found that the latter distribute differently from standard vesicles or free protein alone whereas aromatic polyamino acid-vesicles concentrate in the liver and spleen to a greater extent than standard vesicles. We conclude that the permeability and stability characteristics of vesicles may be preserved when they are modified by the addition of protein or polyamino acids and that such modification of vesicles may be associated with an alteration of their fate in vivo. The potential exists to use vesicles as carriers of radiopharmaceuticals and other drugs and to direct the vesicles preferentially to tissue targets in vivo.
D000818:Animals; D000906:Antibodies; D001666:Binding Sites, Antibody; D005732:Gangliosides / Q000378:metabolism; D007074:Immunoglobulin G / Q000378:metabolism; D007457:Iodine Radioisotopes; D008099:Liver / Q000378:metabolism; D008567:Membranes, Artificial; D008722:Methods; D051379:Mice; D008809:Mice, Inbred C3H; D008863:Microspheres; D010455:Peptides / Q000378:metabolism; D010713:Phosphatidylcholines / Q000378:metabolism; D011485:Protein Binding; D011506:Proteins / Q000378:metabolism; D011868:Radioisotopes; D013154:Spleen / Q000378:metabolism; D013667:Technetium
D000906:Antibodies; D005732:Gangliosides; D007074:Immunoglobulin G; D007457:Iodine Radioisotopes; D008567:Membranes, Artificial; D010455:Peptides; D010713:Phosphatidylcholines; D011506:Proteins; D011868:Radioisotopes; D013667:Technetium